Colorectal cancer remains one of the deadliest cancers worldwide, partly because colonoscopies—though highly accurate—are costly and invasive, leading many to…
Browsing: Clinical Updates
Guardant Health announced updated clinical results for its Shield™ blood test, showing 84% sensitivity and 90% specificity for detecting colorectal…
Patients are increasingly sharing stool photos with gastroenterologists to better describe symptoms that words may obscure. While sometimes awkward, these…
A prospective study led by Penn Medicine researchers shows that genetic screening for DPYD and UGT1A1 variants before chemotherapy can…
Noncolorectal gastrointestinal cancers — including gastric, esophageal, pancreatic, hepatocellular, biliary tract, and neuroendocrine tumors — are often diagnosed late and…
The FDA has awarded breakthrough device designation to Quest Diagnostics’ Haystack MRD test, a highly sensitive ctDNA assay designed for…
Crohn’s disease is notoriously complex: symptoms often lag behind disease progression, making early diagnosis and intervention difficult. To address this,…
A novel “off-the-shelf” vaccine, ELI-002 2P (Elicio Therapeutics), has delivered encouraging results in a phase 1 study for patients with…
The American Gastroenterological Association has teamed up with healthcare data analytics firm Latica to pioneer a real-world evidence (RWE) study…
A new analysis presented at DDW 2025 shows just how much a gastroenterologist’s vs. a surgeon’s perspective can shape GERD…